Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$7.14 USD
-0.66 (-8.46%)
Updated Oct 2, 2023 04:00 PM ET
After-Market: $7.14 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Detailed Estimates
Estimates
Exp Earnings Date | 11/1/23 |
---|---|
Current Quarter | -0.64 |
EPS Last Quarter | -0.56 |
Last EPS Surprise | 26.32% |
ABR | 2.18 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.55 |
Next Year | -2.68 |
EPS (TTM) | -2.96 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.06M | 5.23M | 20.12M | 23.72M |
# of Estimates | 6 | 6 | 9 | 7 |
High Estimate | 6.80M | 7.50M | 27.00M | 50.00M |
Low Estimate | 2.89M | 2.89M | 12.70M | 8.00M |
Year ago Sales | 0.04M | 6.54M | 19.71M | 20.12M |
Year over Year Growth Est. | 12,545.00% | -20.03% | 2.06% | 17.93% |
Earnings Estimates
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.64 | -0.69 | -2.55 | -2.68 |
# of Estimates | 10 | 8 | 12 | 12 |
Most Recent Consensus | -0.60 | -0.55 | -2.35 | -3.53 |
High Estimate | -0.45 | -0.49 | -2.15 | -2.07 |
Low Estimate | -0.86 | -0.98 | -3.15 | -4.10 |
Year ago EPS | -0.81 | -0.88 | -3.21 | -2.55 |
Year over Year Growth Est. | 20.99% | 21.59% | 20.56% | -5.10% |
Agreement - Estimate Revisions
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 5 | 4 | 10 | 8 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 3 | 3 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Current | -0.64 | -0.69 | -2.55 | -2.68 |
7 Days Ago | -0.64 | -0.69 | -2.55 | -2.68 |
30 Days Ago | -0.64 | -0.69 | -2.55 | -2.68 |
60 Days Ago | -0.75 | -0.72 | -3.02 | -3.03 |
90 Days Ago | -0.75 | -0.72 | -3.02 | -3.09 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.64 | -0.69 | -2.55 | -3.53 |
Zacks Consensus Estimate | -0.64 | -0.69 | -2.55 | -2.68 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -31.68% |
Surprise - Reported Earnings History
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Quarter Ending (12/2022) |
Quarter Ending (9/2022) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.56 | -0.71 | -0.88 | -0.81 | NA |
Estimate | -0.76 | -0.79 | -0.84 | -0.87 | NA |
Difference | 0.20 | 0.08 | -0.04 | 0.06 | 0.08 |
Surprise | 26.32% | 10.13% | -4.76% | 6.90% | 9.65% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more